Skip to main content

White Blood Cell and Platelet Disorders

An overview of hematological disorders affecting white blood cells and platelets, including leukocytosis, leukopenia, leukemia, lymphoma, myeloma, infectious mononucleosis, and platelet and blood-clotting disorders.

Save this reading to your study set

Sign up free

The blood is a complex fluid connective tissue composed of a liquid matrix called plasma and various formed elements. These formed elements include erythrocytes (red blood cells), leukocytes (white blood cells), and platelets. While erythrocytes are primarily responsible for gas transport, the leukocytes and platelets serve as the body's primary defense and repair mechanisms. When the production, count, or function of these cells is disrupted, it leads to hematological disorders known as blood dyscrasias. This article examines the various pathologies associated with white blood cells, platelets, and the mechanisms of blood clotting.

White Blood Cell Disorders

White blood cells (WBCs) are the cornerstone of the immune system, categorized into the myeloid lineage (granulocytes and monocytes) and the lymphoid lineage (B, T, and NK cells). Disorders in this category typically involve abnormal cell counts or dysfunctional cellular activity.

Leukocytosis and Leukopenia

The most basic classifications of WBC disorders involve the total count of cells in circulation. Leukocytosis refers to an elevated WBC count (>11,000>11,000 cells/μl\mu\text{l}), which is often a physiological response to infection, inflammation, or a sign of underlying leukemia. Conversely, leukopenia is a decreased WBC count (<4,000<4,000 cells/μl\mu\text{l}), which significantly increases a patient's susceptibility to infection. This can be caused by bone marrow failure, certain drugs, or viral infections.

Hematological Malignancies: Leukemia, Lymphoma, and Myeloma

When the hematopoietic process becomes uncontrolled, cancers arise.

  • Leukemia: This is a cancer of the blood-forming tissues characterized by the uncontrolled proliferation of white blood cells. As these malignant cells crowd the bone marrow, they cause bone marrow failure, which leads to secondary issues like anemia (low RBCs) and thrombocytopenia (low platelets).
  • Lymphoma: Unlike leukemia, which is primarily in the blood and marrow, lymphoma is a cancer of the lymphocytes (B or T cells) that accumulates in the lymphatic tissues, thereby disrupting systemic immune function.
  • Myeloma: This is a cancer specifically affecting plasma cells. Malignant plasma cells can cause significant damage, including bone destruction (lytic lesions), renal injury due to the accumulation of monoclonal proteins, and general immunodeficiency.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.